Skip to main content
OpenTrials

Clinical trial condition

Brain and Central Nervous System Tumors

Explore clinical trials studying Brain and Central Nervous System Tumors. Study availability and eligibility vary by location and protocol.

309 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Brain and Central Nervous System Tumors trial results

Completed

Topotecan in Treating Patients With Recurrent Brain Tumors

NCT00003372

Conditions
Brain Diseases, Brain Neoplasms, Brain and Central Nervous System Tumors, +14 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

SarCNU in Treating Patients With Recurrent Malignant Glioma

NCT00036660

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
  • Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada
  • Toronto General Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00869401

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Helen and Harry Gray Cancer Center at Hartford Hospital Hartford, Connecticut, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • John B. Amos Cancer Center Columbus, Georgia, United States
  • Illinois CancerCare - Bloomington Bloomington, Illinois, United States
View all 207 locations
View Trial Details
Completed

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

NCT00553150

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center Boise, Idaho, United States
View all 178 locations
View Trial Details
Completed

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas

NCT00004259

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +11 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Enloe Cancer Center at Enloe Medical Center Chico, California, United States
  • North Bay Cancer Center Fairfield, California, United States
View all 92 locations
View Trial Details
Completed

Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00486603

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

NCT01480050

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View Trial Details

Related conditions